FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3173031569> ?p ?o ?g. }

• W3173031569 endingPage "20201396" @default.
• W3173031569 startingPage "20201396" @default.
• W3173031569 abstract "Better markers of early response to neoadjuvant chemotherapy (NACT) in patients with breast cancer are required to enable the timely identification of non-responders and reduce unnecessary treatment side-effects. Early functional imaging may better predict response to treatment than conventional measures of tumour size. The purpose of this study was to test the hypothesis that the change in tumour blood flow after one cycle of NACT would predict pathological response.In this prospective cohort study, dynamic contrast-enhanced MRI was performed in 35 females with breast cancer before and after one cycle of epirubicin and cyclophosphamide-based NACT (EC90). Estimates of tumour blood flow and tumour volume were compared with pathological response obtained at surgery following completion of NACT.Tumour blood flow at baseline (mean ± SD; 0.32 ± 0.17 ml/min/ml) reduced slightly after one cycle of NACT (0.28 ± 0.18 ml/min/ml). Following treatment 15 patients were identified as pathological responders and 20 as non-responders. There were no relationships found between tumour blood flow and pathological response. Conversely, tumour volume was found to be a good predictor of pathological response (smaller tumours did better) at both baseline (area under the receiver operating characteristic curve 0.80) and after one cycle of NACT (area under the receiver operating characteristic curve 0.81).The change in breast tumour blood flow following one cycle of EC90 did not predict pathological response. Tumour volume may be a better early marker of response with such agents." @default.
• W3173031569 created "2021-06-22" @default.
• W3173031569 creator A5002501617 @default.
• W3173031569 creator A5002979606 @default.
• W3173031569 creator A5006823745 @default.
• W3173031569 creator A5012392332 @default.
• W3173031569 creator A5015824949 @default.
• W3173031569 creator A5033365312 @default.
• W3173031569 creator A5033485831 @default.
• W3173031569 creator A5063918475 @default.
• W3173031569 creator A5066956278 @default.
• W3173031569 creator A5081330872 @default.
• W3173031569 creator A5083421034 @default.
• W3173031569 creator A5083614584 @default.
• W3173031569 date "2021-07-01" @default.
• W3173031569 modified "2023-09-27" @default.
• W3173031569 title "Breast tumour volume and blood flow measured by MRI after one cycle of epirubicin and cyclophosphamide-based neoadjuvant chemotherapy as predictors of pathological response" @default.
• W3173031569 cites W1987326983 @default.
• W3173031569 cites W2001974555 @default.
• W3173031569 cites W2006816753 @default.
• W3173031569 cites W2038312994 @default.
• W3173031569 cites W2038833688 @default.
• W3173031569 cites W2042806233 @default.
• W3173031569 cites W2052182503 @default.
• W3173031569 cites W2074145540 @default.
• W3173031569 cites W2096145980 @default.
• W3173031569 cites W2100042237 @default.
• W3173031569 cites W2106453614 @default.
• W3173031569 cites W2113453484 @default.
• W3173031569 cites W2121068794 @default.
• W3173031569 cites W2132298704 @default.
• W3173031569 cites W2138192032 @default.
• W3173031569 cites W2142148333 @default.
• W3173031569 cites W2143910081 @default.
• W3173031569 cites W2182711918 @default.
• W3173031569 cites W2315013432 @default.
• W3173031569 cites W2604991108 @default.
• W3173031569 cites W2766525994 @default.
• W3173031569 cites W2786489953 @default.
• W3173031569 cites W2893824982 @default.
• W3173031569 cites W2941465200 @default.
• W3173031569 cites W3005915104 @default.
• W3173031569 cites W302053188 @default.
• W3173031569 doi "https://doi.org/10.1259/bjr.20201396" @default.
• W3173031569 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/8248209" @default.
• W3173031569 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/34106751" @default.
• W3173031569 hasPublicationYear "2021" @default.
• W3173031569 type Work @default.
• W3173031569 sameAs 3173031569 @default.
• W3173031569 citedByCount "3" @default.
• W3173031569 countsByYear W31730315692022 @default.
• W3173031569 countsByYear W31730315692023 @default.
• W3173031569 crossrefType "journal-article" @default.
• W3173031569 hasAuthorship W3173031569A5002501617 @default.
• W3173031569 hasAuthorship W3173031569A5002979606 @default.
• W3173031569 hasAuthorship W3173031569A5006823745 @default.
• W3173031569 hasAuthorship W3173031569A5012392332 @default.
• W3173031569 hasAuthorship W3173031569A5015824949 @default.
• W3173031569 hasAuthorship W3173031569A5033365312 @default.
• W3173031569 hasAuthorship W3173031569A5033485831 @default.
• W3173031569 hasAuthorship W3173031569A5063918475 @default.
• W3173031569 hasAuthorship W3173031569A5066956278 @default.
• W3173031569 hasAuthorship W3173031569A5081330872 @default.
• W3173031569 hasAuthorship W3173031569A5083421034 @default.
• W3173031569 hasAuthorship W3173031569A5083614584 @default.
• W3173031569 hasBestOaLocation W31730315691 @default.
• W3173031569 hasConcept C121608353 @default.
• W3173031569 hasConcept C126322002 @default.
• W3173031569 hasConcept C126838900 @default.
• W3173031569 hasConcept C126894567 @default.
• W3173031569 hasConcept C143998085 @default.
• W3173031569 hasConcept C146357865 @default.
• W3173031569 hasConcept C151730666 @default.
• W3173031569 hasConcept C158846371 @default.
• W3173031569 hasConcept C207886595 @default.
• W3173031569 hasConcept C2776694085 @default.
• W3173031569 hasConcept C2776755627 @default.
• W3173031569 hasConcept C2778292576 @default.
• W3173031569 hasConcept C2780835546 @default.
• W3173031569 hasConcept C530470458 @default.
• W3173031569 hasConcept C58471807 @default.
• W3173031569 hasConcept C71924100 @default.
• W3173031569 hasConcept C86803240 @default.
• W3173031569 hasConceptScore W3173031569C121608353 @default.
• W3173031569 hasConceptScore W3173031569C126322002 @default.
• W3173031569 hasConceptScore W3173031569C126838900 @default.
• W3173031569 hasConceptScore W3173031569C126894567 @default.
• W3173031569 hasConceptScore W3173031569C143998085 @default.
• W3173031569 hasConceptScore W3173031569C146357865 @default.
• W3173031569 hasConceptScore W3173031569C151730666 @default.
• W3173031569 hasConceptScore W3173031569C158846371 @default.
• W3173031569 hasConceptScore W3173031569C207886595 @default.
• W3173031569 hasConceptScore W3173031569C2776694085 @default.
• W3173031569 hasConceptScore W3173031569C2776755627 @default.
• W3173031569 hasConceptScore W3173031569C2778292576 @default.
• W3173031569 hasConceptScore W3173031569C2780835546 @default.
• W3173031569 hasConceptScore W3173031569C530470458 @default.
• W3173031569 hasConceptScore W3173031569C58471807 @default.

• next